Loading stock data…
Grace Therapeutics (GRCE)
$2.30-0.08 (-3.36%)
After Hours$2.30+0.00 (+0.00%)· Last close Jun 29
Grace Therapeutics, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Grace Therapeutics, Inc. in the Healthcare sector is trading at $2.30 with a market capitalization of $34M. Wall Street consensus targets $5.95 (2 analysts), implying a +158.7% move over the next 12 months. The stock is currently near its 52-week low of $1.79, remaining 29.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +158.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.45M↑ | -$2.53M↑ | -$3.09M↑ | -$3.18M↑ | -$3.70M |
| Net Income | -$2.31M↓ | -$938,000↑ | -$3.36M↓ | $636,000↑ | -$4.16M |
Peer Comparison
JNJUNHPFE
Fundamentals
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$33.70M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.21%
Volume
Today's trading volume
970,647
Recent News
Sector Update: Health Care Stocks Edge Lower Late Afternoon
Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the Stat
We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, Grace...
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year
Insiders were net buyers of Grace Therapeutics, Inc.'s ( NASDAQ:GRCE ) stock during the past year. That is, insiders...
We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...